Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Anton Simeonov and Richard Eastman.
Anton Simeonov
Connection Strength
0.616
Richard Eastman
  1. Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19. ACS Cent Sci. 2020 06 24; 6(6):1009.
    View in: PubMed
    Score: 0.222
  2. Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19. ACS Cent Sci. 2020 May 27; 6(5):672-683.
    View in: PubMed
    Score: 0.220
  3. Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection. Bioorg Med Chem Lett. 2021 05 15; 40:127906.
    View in: PubMed
    Score: 0.058
  4. Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2. Front Pharmacol. 2020; 11:592737.
    View in: PubMed
    Score: 0.058
  5. Synergistic and Antagonistic Drug Combinations against SARS-CoV-2. Mol Ther. 2021 02 03; 29(2):873-885.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.